These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23887618)

  • 1. Caution is needed when interpreting changes of matrix metalloproteinase-3 in patients with rheumatoid arthritis.
    Nagashima T; Minota S
    Rheumatol Int; 2014 Jul; 34(7):1025-6. PubMed ID: 23887618
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience.
    Epis O; Casu C; Belloli L; Schito E; Filippini D; Muscarà M; Bruschi E
    Rheumatol Int; 2015 Sep; 35(9):1569-70. PubMed ID: 25773656
    [No Abstract]   [Full Text] [Related]  

  • 3. Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for 2 years.
    Suzuki T; Hirota T; Ogishima H; Umeda N; Kondo Y; Yokosawa M; Miki H; Tsuboi H; Matsumoto I; Sumida T
    Int J Rheum Dis; 2015 Jan; 18(1):108-10. PubMed ID: 25294091
    [No Abstract]   [Full Text] [Related]  

  • 4. Tocilizumab: is there life beyond anti-TNF blockade?
    Alves JD; Marinho A; Serra MJ
    Int J Clin Pract; 2011 Apr; 65(4):508-13. PubMed ID: 21272164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline levels of soluble interleukin-6 receptor predict clinical remission in patients with rheumatoid arthritis treated with tocilizumab: implications for molecular targeted therapy.
    Nishina N; Kikuchi J; Hashizume M; Yoshimoto K; Kameda H; Takeuchi T
    Ann Rheum Dis; 2014 May; 73(5):945-7. PubMed ID: 24336338
    [No Abstract]   [Full Text] [Related]  

  • 6. A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study.
    Heimans L; Wevers-de Boer KV; Visser K; Goekoop RJ; van Oosterhout M; Harbers JB; Bijkerk C; Speyer I; de Buck MP; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
    Ann Rheum Dis; 2014 Jul; 73(7):1356-61. PubMed ID: 23716067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline low modified health assessment questionnaire (MHAQ) predicts the state of remission estimated by clinical disease activity index and MHAQ at 1 year in tocilizumab-treated rheumatoid arthritis patients.
    Kawashiri S; Ueki Y; Migita K; Nakamura H; Aoyagi K; Kawakami A
    Clin Exp Rheumatol; 2014; 32(3):445. PubMed ID: 24850342
    [No Abstract]   [Full Text] [Related]  

  • 8. [A patient with rheumatoid arthritis and primary biliary cirrhosis successfully treated with adalimumab].
    Bakula M; Mayer M; Čikeš N; Anić B
    Lijec Vjesn; 2015; 137(1-2):27-9. PubMed ID: 25906545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks.
    Yokoe I; Nishio S; Sato H; Kobayashi H
    Mod Rheumatol; 2011 Dec; 21(6):710-4. PubMed ID: 21656090
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission after Six Months of Non-tumor Necrosis Factor Biological Disease-Modifying Antirheumatic Drugs (DMARDs) Treatment.
    Miwa Y; Saito M; Furuya H; Yanai R; Ikari Y; Hayashi T; Kasama T; Toyoshima Y; Inagaki K
    Intern Med; 2017 Sep; 56(17):2271-2275. PubMed ID: 28794381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical results for tocilizumab over one year in the clinical setting as assessed by CDAI (clinical disease activity index): CRP at week 12 and MMP-3 at week 24 are predictive factors for CDAI.
    Kaneko A; Kida D; Saito K; Tsukamoto M; Sato T
    Rheumatol Int; 2012 Nov; 32(11):3631-7. PubMed ID: 22127466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarilumab (Kevzara) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2017 Aug; 59(1527):134-136. PubMed ID: 28787744
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: inflammation, disease-modifying antirheumatic drugs, lipids, and cardiovascular risk in rheumatoid arthritis.
    Liao KP; Solomon DH
    Arthritis Rheumatol; 2015 Feb; 67(2):327-9. PubMed ID: 25331004
    [No Abstract]   [Full Text] [Related]  

  • 14. Beyond methotrexate monotherapy for early rheumatoid arthritis.
    Scott DL
    Lancet; 2016 Jul; 388(10042):309-310. PubMed ID: 27287831
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of clinical remission with adalimumab-methotrexate combination therapy in a patient with rheumatoid arthritis and concomitant hepatitis C virus infection.
    Noguchi O; Gibo Y
    Mod Rheumatol; 2011 Dec; 21(6):696-700. PubMed ID: 21607710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological treatment in rheumatoid arthritis: when to stop?
    Kirwan JR; Boers M
    Lancet; 2014 Jan; 383(9914):288-9. PubMed ID: 24168959
    [No Abstract]   [Full Text] [Related]  

  • 17. Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis.
    Andrisani G; Gremese E; Guidi L; Papa A; Marzo M; Felice C; Pugliese D; Armuzzi A
    Reumatismo; 2013 May; 65(2):75-8. PubMed ID: 23877411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission in rheumatoid arthritis: missing objectives by using inadequate DAS28 targets.
    Aletaha D; Smolen JS
    Nat Rev Rheumatol; 2019 Nov; 15(11):633-634. PubMed ID: 31427763
    [No Abstract]   [Full Text] [Related]  

  • 19. Comment on: tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice.
    Besada E
    Rheumatology (Oxford); 2015 Apr; 54(4):751. PubMed ID: 25602064
    [No Abstract]   [Full Text] [Related]  

  • 20. Comment on: tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice: reply.
    Fortunet C; Maillefert JF
    Rheumatology (Oxford); 2015 Apr; 54(4):751-2. PubMed ID: 25602063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.